Lex Houdijk

Lex Houdijk is an accomplished scientific researcher with over 100 peer-reviewed publications, currently serving at Noordwest Ziekenhuisgroep since February 2003. In addition to this role, Lex Houdijk is a co-founder of both PreventiMed BV, where a focus on gastrointestinal endocrine surgery is central, and frelex, which specializes in medical device development. Previously, Lex Houdijk managed programs at Trial Center Holland Health from February 2013 to August 2016, aimed at enhancing human research professionalism. Lex Houdijk's extensive educational background includes a Doctor of Philosophy degree from Vrije Universiteit Amsterdam, a medical degree from Erasmus University Rotterdam, and a surgical intensive care residency at Harvard Medical School.